Jong Wook Chang has completed his Ph.D in 2005 from Gwangju-Institute of Science & Technology and postdoctoral studies from Korea-Institute of Science & Technology. He is the NEUROSTEM team leader of Biomedical Research Institute in MEDIPOST Co.,Ltd, a leading group of cord blood MSC therapeutics in South Korea. He also has been worked as a project manager for phase I clinical trial for AD using hUCB-MSC. He has published more than 13 papers after 2008 in reputed journals regarding stem cells and serving as an editorial board member of World Journal of Stem cells.   Jong Wook Chang has completed his Ph.D in 2005 from Gwangju-Institute of Science & Technology and postdoctoral studies from Korea-Institute of Science & Technology. He is the NEUROSTEM team leader of Biomedical Research Institute in MEDIPOST Co.,Ltd, a leading group of cord blood MSC therapeutics in South Korea. He also has been worked as a project manager for phase I clinical trial for AD using hUCB-MSC. He has published more than 13 papers after 2008 in reputed journals regarding stem cells and serving as an editorial board member of World Journal of Stem cells.  

Genetics and Molecular Biology